Application 021183
- Type
- NDA
- Sponsor
- BRISTOL MYERS SQUIBB
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VIDEX EC | DIDANOSINE | CAPSULE, DELAYED REL PELLETS;ORAL | 125MG | Yes | No |
| 002 | VIDEX EC | DIDANOSINE | CAPSULE, DELAYED REL PELLETS;ORAL | 200MG | Yes | No |
| 003 | VIDEX EC | DIDANOSINE | CAPSULE, DELAYED REL PELLETS;ORAL | 250MG | Yes | No |
| 004 | VIDEX EC | DIDANOSINE | CAPSULE, DELAYED REL PELLETS;ORAL | 400MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021183-001 | VIDEX EC | DIDANOSINE | 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | |
| N021183-002 | VIDEX EC | DIDANOSINE | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | |
| N021183-003 | VIDEX EC | DIDANOSINE | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | |
| N021183-004 | VIDEX EC | DIDANOSINE | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021183-001 | VIDEX EC | 125MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | RLD | 2000-10-31 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021183-002 | VIDEX EC | 200MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | RLD | 2000-10-31 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021183-003 | VIDEX EC | 250MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | RLD | 2000-10-31 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021183-004 | VIDEX EC | 400MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | RLD, RS | 2000-10-31 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N021183-001 | VIDEX EC | 125MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021183-002 | VIDEX EC | 200MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021183-003 | VIDEX EC | 250MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021183-004 | VIDEX EC | 400MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021183-001 | VIDEX EC | 125MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021183-002 | VIDEX EC | 200MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021183-003 | VIDEX EC | 250MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021183-004 | VIDEX EC | 400MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021183-001 | VIDEX EC | 125MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021183-002 | VIDEX EC | 200MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021183-003 | VIDEX EC | 250MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021183-004 | VIDEX EC | 400MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021183-001 | VIDEX EC | 125MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021183-002 | VIDEX EC | 200MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021183-003 | VIDEX EC | 250MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021183-004 | VIDEX EC | 400MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021183-001 | VIDEX EC | 125MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021183-002 | VIDEX EC | 200MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021183-003 | VIDEX EC | 250MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021183-004 | VIDEX EC | 400MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021183-001 | VIDEX EC | 125MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021183-002 | VIDEX EC | 200MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021183-003 | VIDEX EC | 250MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021183-004 | VIDEX EC | 400MG | CAPSULE, DELAYED REL PELLETS / ORAL | RLD | 2000-10-31 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021183-001 | VIDEX EC | 125MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | RLD | 2000-10-31 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N021183-002 | VIDEX EC | 200MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | RLD | 2000-10-31 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N021183-003 | VIDEX EC | 250MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | RLD | 2000-10-31 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N021183-004 | VIDEX EC | 400MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | RLD, RS | 2000-10-31 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N021183-001 | VIDEX EC | 125MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | RLD | 2000-10-31 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N021183-002 | VIDEX EC | 200MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | RLD | 2000-10-31 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N021183-003 | VIDEX EC | 250MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | RLD | 2000-10-31 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N021183-004 | VIDEX EC | 400MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | RLD, RS | 2000-10-31 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N021183-001 | VIDEX EC | 125MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | RLD | 2000-10-31 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N021183-002 | VIDEX EC | 200MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | RLD | 2000-10-31 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N021183-003 | VIDEX EC | 250MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | RLD | 2000-10-31 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N021183-004 | VIDEX EC | 400MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | RLD, RS | 2000-10-31 | ea99ee380514… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021183-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021183-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021183-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021183-004 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | N021183-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N021183-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N021183-003 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N021183-004 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N021183-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N021183-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N021183-003 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N021183-004 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N021183-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N021183-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N021183-003 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N021183-004 | AB | 1 | ea99ee380514… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0087-6671 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6671 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6671 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6672 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6672 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6672 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6673 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6673 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6673 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6674 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6674 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6674 | VIDEX EC | didanosine | Bristol-Myers Squibb Company | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 56915 | SUPPL | 2018-12-21 |
| 56770 | SUPPL | 2018-12-18 |
| 56769 | SUPPL | 2018-12-18 |
| 52103 | SUPPL | 2018-01-30 |
| 52079 | SUPPL | 2018-01-25 |
| 14603 | SUPPL | 2011-11-22 |
| 4594 | SUPPL | 2011-11-22 |
| 4593 | SUPPL | 2011-05-12 |
| 44103 | ORIG | 2010-08-09 |
| 4592 | SUPPL | 2010-02-01 |
| 14602 | SUPPL | 2010-01-29 |
| 14601 | SUPPL | 2009-06-22 |
| 27019 | SUPPL | 2009-06-16 |
| 36312 | SUPPL | 2008-10-03 |
| 4591 | SUPPL | 2008-10-02 |
| 21496 | SUPPL | 2007-07-09 |
| 4590 | SUPPL | 2006-12-28 |
| 14600 | SUPPL | 2006-12-04 |
| 27018 | SUPPL | 2006-09-18 |
| 36311 | SUPPL | 2006-08-21 |
| 42008 | SUPPL | 2005-04-08 |
| 4584 | ORIG | 2004-06-30 |
| 21495 | ORIG | 2004-03-11 |
| 36310 | SUPPL | 2004-01-22 |
| 4589 | SUPPL | 2004-01-22 |
| 27017 | SUPPL | 2003-03-10 |
| 14599 | SUPPL | 2003-03-07 |
| 36309 | SUPPL | 2002-09-26 |
| 27016 | SUPPL | 2002-09-26 |
| 14598 | SUPPL | 2002-09-26 |
| 4588 | SUPPL | 2002-09-26 |
| 14597 | SUPPL | 2002-08-05 |
| 4587 | SUPPL | 2002-08-05 |
| 36308 | SUPPL | 2002-04-01 |
| 27015 | SUPPL | 2002-04-01 |
| 4586 | SUPPL | 2002-01-29 |
| 4585 | SUPPL | 2002-01-28 |
| 36307 | ORIG | 2000-10-31 |
| 53231 | SUPPL | 1900-01-01 |
| 53230 | SUPPL | 1900-01-01 |